Ventas, Inc. — Cyborg Score 8/10

Strong
Healthcare Real Estate Investment Trust (REIT) - Senior Housing & Medical Office

Strategic Profile

Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OI platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities.

Cyborg Score Rationale

In 2025, Ventas's revenue was $5.82 billion, an increase of 18.99% compared to the previous year's $4.89 billion. According to 13 analysts, the average rating for VTR stock is 'Buy.' Strong demographic tailwinds from an aging population provide sustained growth opportunities.

Top Insights

  • Revenue grew 19% YoY to $5.82B in 2025 with earnings up 210%
  • Senior Housing Operating Portfolio (SHOP) delivered double-digit NOI growth with accelerating occupancy
  • Strong demographic tailwinds, constrained supply, and accelerating investment activity support multi-year NOI growth
  • Raised quarterly cash dividend to $0.48 per share, declared December 2025

Named Competitors

  • Welltower — Diversified healthcare REIT with senior housing and medical offices
  • Healthpeak Properties — Healthcare REIT focused on life science and medical office
  • Omega Healthcare Investors — Skilled nursing facility and senior housing REIT
  • National Health Investors — Senior housing and medical office REIT

Recent Developments

  • (December 2025) Announced quarterly dividend of $0.48 per share
  • (January 2026) Announced Peter Bulgarelli retirement effective May 1, 2026
  • (Q3 2025) Reported strong operational results with senior housing segment driving growth

Open the full interactive Ventas, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →